Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bevacizumab in combination chemotherapy for lymph node-positive breast cancer. The study included male breast cancer and various…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Stage II Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-04-28